Symic Biomedical
Emeryville
About Symic Biomedical
Symic Biomedical is a developer of matrix regulator therapeutics designed to affect matrix degradation and structure. The company's therapeutics bind to targets in the matrix, damaged in response to injury or because of disease, to inhibit pathological inflammatory responses, enabling clinicians to investigate applications in the areas of fibrosis, oncology and diseases of the central nervous system.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $84.1M
- Funding stage: Late Stage Venture
- Last round: Series C (Apr 2019)
- Website: symic.bio
- Phone: 1(415) 805-9005
Industries & Categories
Biotechnology, Business Intelligence, Health Care
Social Profiles
Canonical: https://fsome.com/organization/symic-biomedical-60048 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.